跳至主要内容
临床试验/IRCT2016021123298N3
IRCT2016021123298N3已完成1 期

The Effect And Safety Of Allogenic Adipose-Derived Mesenchymal Stem Cells In Treatment Of Knee Osteoarthritis, Pilot Study

Vice Chancellor For Research Of Iran University of Medical Science0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 75 years(—)
性别
All

入选标准

  • inclusion criteria: knee osteoarthritis based on ACR (American College of Rheumatology) criteria and grade 1,2,3 based on Kellgren-Lawrence grading scale; Ability to follow during the study period exclusion criteria: age <18 and >75 years; presence of any acute or chronic infectious process; knee deformity (varus >10 ° or valgus >20° ); impaired renal function(creatinine>2.0 mg/dl); impaired liver function(Bilirubin > 2.0 ?/?, AST/ALT > 100 IU/L); Pregnancy or lactating; neoplasia; BMI>35; Immunosuppressive state; Systemic autoimmune rheumatic disease or secondary osteoarthritis; intraarthicular injections in last 3 months; history of knee surgery; Poorly controlled diabetes mellitus

排除标准

  • 未提供

研究者

发起方
Vice Chancellor For Research Of Iran University of Medical Science

相似试验

Mesenchymal Stem Cells In Treatment Of Knee... | 临床试验